연구성과로 돌아가기

2021 연구자 정보 (478 / 1146)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Jia, Xuanxuan
(Jia, XX)
제1저자 Shandong Normal Univ, Inst Mat & Clean Energy, Coll Chem Chem Engn & Mat Sci, Shandong Prov Key Lab Clean Prod Fine Chem, Jinan 250014, Peoples R China

[JCR상위 19.7] Understanding the high performance of an iron-antimony binary metal oxide catalyst in selective catalytic reduction of nitric oxide with ammonia and its tolerance of water/sulfur dioxide SCIE 19.7 CHEMISTRY, PHYSICAL suncz@sdnu.edu.cn;
Kang, Kyoung-Ku
(Kang, KK)
Chungnam Natl Univ, Dept Chem Engn & Appl Chem, Daejeon 305764, South Korea HLX-0854-2023
Kang, Kyoung-Ku

[JCR상위 19.7] Aqueous Nd³⁺ capture using a carboxyl-functionalized porous carbon derived from ZIF-8 SCIE 19.7 CHEMISTRY, PHYSICAL rhadum@cnu.ac.kr;whasahn@inha.ac.kr;
Liu, Hao
(Liu, H)
Shandong Normal Univ, Inst Mat & Clean Energy, Coll Chem Chem Engn & Mat Sci, Shandong Prov Key Lab Clean Prod Fine Chem, Jinan 250014, Peoples R China
Kyungpook Natl Univ, Sch Energy Engn, Daegu 41566, South Korea
Hebei Univ Technol, Sch Mat Sci & Engn, Tianjin 300130, Peoples R China

0000-0001-6849-7269
0000-0003-0053-5868
Liu, Hao
[JCR상위 19.7] Understanding the high performance of an iron-antimony binary metal oxide catalyst in selective catalytic reduction of nitric oxide with ammonia and its tolerance of water/sulfur dioxide
[JCR상위 31.0] A Comprehensive Study of Dynamic Recrystallization Behavior of Mg Alloy with 3 wt.% Bi Addition
SCIE 19.7 CHEMISTRY, PHYSICAL
MATERIALS SCIENCE, MULTIDISCIPLINARY;METALLURGY & METALLURGICAL ENGINEERING
suncz@sdnu.edu.cn;
huiyu@vip.126.com;18447071543@163.com;sympathy1988@163.com;yuwei52213@163.com;kangdashao@163.com;chengweili7@126.com;shpark@kims.re.kr;chendong19832021@163.com;yinfuxing@hebutedu.cn;ksshin@snu.ac.kr;jinyao@dongyimg.com;pm01@dongyimg.com;rdc11@dongyimg.com;
Sun, Chuanzhi
(Sun, CZ)
교신저자 Shandong Normal Univ, Inst Mat & Clean Energy, Coll Chem Chem Engn & Mat Sci, Shandong Prov Key Lab Clean Prod Fine Chem, Jinan 250014, Peoples R China

[JCR상위 19.7] Understanding the high performance of an iron-antimony binary metal oxide catalyst in selective catalytic reduction of nitric oxide with ammonia and its tolerance of water/sulfur dioxide SCIE 19.7 CHEMISTRY, PHYSICAL suncz@sdnu.edu.cn;
Tong, Qing
(Tong, Q)
Nanjing Univ, Sch Environm, Ctr Modern Anal, Jiangsu Key Lab Vehicle Emiss Control, Nanjing 210093, Peoples R China

[JCR상위 19.7] Understanding the high performance of an iron-antimony binary metal oxide catalyst in selective catalytic reduction of nitric oxide with ammonia and its tolerance of water/sulfur dioxide SCIE 19.7 CHEMISTRY, PHYSICAL suncz@sdnu.edu.cn;
Zhang, Yu
(Zhang, Y)
Shandong Normal Univ, Inst Mat & Clean Energy, Coll Chem Chem Engn & Mat Sci, Shandong Prov Key Lab Clean Prod Fine Chem, Jinan 250014, Peoples R China F-2078-2011
Zhang, Yu-Yang

[JCR상위 19.7] Understanding the high performance of an iron-antimony binary metal oxide catalyst in selective catalytic reduction of nitric oxide with ammonia and its tolerance of water/sulfur dioxide SCIE 19.7 CHEMISTRY, PHYSICAL suncz@sdnu.edu.cn;
Ahn, Ji Yong
(Ahn, JY)
Univ Ulsan, Asan Med Ctr, Dept Internal Med, Div Gastroenterol,Coll Med, Seoul, South Korea
Univ Ulsan, Coll Med, Asan Med Ctr, Div Gastroenterol,Dept Internal Med, Seoul, South Korea
AGO-1695-2022
Ahn, Ji Yong

[JCR상위 19.8] Clinical outcomes of endoscopic resection for undifferentiated intramucosal early gastric cancer larger than 2 cm
[JCR상위 46.8] Long-term Outcomes of Undifferentiated-Type Early Gastric Cancer with Positive Horizontal Margins after Endoscopic Resection
[JCR상위 19.8] Risk factors of lymph node metastasis after non-curative endoscopic resection of undifferentiated-type early gastric cancer
[JCR상위 19.8] Comparison between endoscopic submucosal resection and surgery for the curative resection of undifferentiated-type early gastric cancer within expanded indications: a nationwide multi-center study
SCIE 19.8 GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY
GASTROENTEROLOGY & HEPATOLOGY
nam20131114@gmail.com;bhmin@skku.edu;
jadelook@hanmail.net;bongsul@daum.net;
jyjang@khu.ac.kr;harley1333@hanmail.net;
sgun9139@gmail.com;
Awasthi, Bhuwan Prasad
(Awasthi, BP)
제1저자 Yeungnam Univ, Coll Pharm, Gyongsan 38541, South Korea MAH-8562-2025
Awasthi, Bhuwan Prasad
0000-0002-2636-510X
Awasthi, Bhuwan Prasad
[JCR상위 19.8] Synthesis and anti-hepatocellular carcinoma activity of aminopyridinol-sorafenib hybrids SCIE 19.8 BIOCHEMISTRY & MOLECULAR BIOLOGY;CHEMISTRY, MEDICINAL jjee@knu.ac.kr;jakim@yu.ac.kr;jeongb@ynu.ac.kr;
Bai, Li-Yuan
(Bai, LY)
China Med Univ, China Med Univ Hosp, Div Hematol & Oncol, Dept Internal Med, Taichung, Taiwan

[JCR상위 19.8] Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab SCIE 19.8 GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY nboku@ncc.go.jp;
Boku, Narikazu
(Boku, N)
제1저자 교신저자 Natl Canc Ctr, Div Gastrointestinal Med Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan
0000-0002-1438-707X
Boku, Narikazu
[JCR상위 19.8] Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab SCIE 19.8 GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY nboku@ncc.go.jp;
Chao, Yee
(Chao, Y)
Taipei Vet Gen Hosp, Dept Oncol, Taipei, Taiwan

[JCR상위 19.8] Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab SCIE 19.8 GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY nboku@ncc.go.jp;
Chaudhary, Prakash
(Chaudhary, P)
Yeungnam Univ, Coll Pharm, Gyongsan 38541, South Korea

[JCR상위 19.8] Synthesis and anti-hepatocellular carcinoma activity of aminopyridinol-sorafenib hybrids
[JCR상위 23.1] Novel Pyridine Bioisostere of Cabozantinib as a Potent c-Met Kinase Inhibitor: Synthesis and Anti-Tumor Activity against Hepatocellular Carcinoma
SCIE 19.8 BIOCHEMISTRY & MOLECULAR BIOLOGY;CHEMISTRY, MEDICINAL
BIOCHEMISTRY & MOLECULAR BIOLOGY;CHEMISTRY, MULTIDISCIPLINARY
jjee@knu.ac.kr;jakim@yu.ac.kr;jeongb@ynu.ac.kr;
Karmacharya@ynu.ac.kr;diwakarguragain@ynu.ac.kr;prakash@ynu.ac.kr;jjee@knu.ac.kr;jakim@yu.ac.kr;jeongb@ynu.ac.kr;
Chen, Jen-Shi
(Chen, JS)
Chang Gung Univ, Linkou Chang Gung Mem Hosp, Dept Internal Med, Div Hematol & Oncol, Taoyuan, Taiwan GLV-3349-2022
Chen, Jen-Shi

[JCR상위 19.8] Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab SCIE 19.8 GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY nboku@ncc.go.jp;
Chen, Li-Tzong
(Chen, LT)
Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan
Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Tainan, Taiwan
Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan


[JCR상위 19.8] Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab SCIE 19.8 GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY nboku@ncc.go.jp;
Chin, Keisho
(Chin, K)
Canc Inst Hosp, Japanese Fdn Canc Res, Dept Gastroenterol, Tokyo, Japan

[JCR상위 19.8] Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab SCIE 19.8 GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY nboku@ncc.go.jp;
페이지 이동: